180 related articles for article (PubMed ID: 30416791)
1. The impact of histology and ground-glass opacity component on volume doubling time in primary lung cancer.
Obayashi K; Shimizu K; Nakazawa S; Nagashima T; Yajima T; Kosaka T; Atsumi J; Kawatani N; Yazawa T; Kaira K; Mogi A; Kuwano H
J Thorac Dis; 2018 Sep; 10(9):5428-5434. PubMed ID: 30416791
[TBL] [Abstract][Full Text] [Related]
2. Management of ground-glass opacities: should all pulmonary lesions with ground-glass opacity be surgically resected?
Kobayashi Y; Mitsudomi T
Transl Lung Cancer Res; 2013 Oct; 2(5):354-63. PubMed ID: 25806254
[TBL] [Abstract][Full Text] [Related]
3. Volume-doubling time of pulmonary nodules with ground glass opacity at multidetector CT: Assessment with computer-aided three-dimensional volumetry.
Oda S; Awai K; Murao K; Ozawa A; Utsunomiya D; Yanaga Y; Kawanaka K; Yamashita Y
Acad Radiol; 2011 Jan; 18(1):63-9. PubMed ID: 21145028
[TBL] [Abstract][Full Text] [Related]
4. PET standardized uptake values of primary lung cancer for comparison with tumor volume doubling times.
Siddique M; Yip R; Henschke CI; Yankelevitz DF
Clin Imaging; 2021 May; 73():146-150. PubMed ID: 33418311
[TBL] [Abstract][Full Text] [Related]
5. A clinicopathological study of resected subcentimeter lung cancers: a favorable prognosis for ground glass opacity lesions.
Asamura H; Suzuki K; Watanabe S; Matsuno Y; Maeshima A; Tsuchiya R
Ann Thorac Surg; 2003 Oct; 76(4):1016-22. PubMed ID: 14529977
[TBL] [Abstract][Full Text] [Related]
6. EGFR L858R mutation is associated with lung adenocarcinoma patients with dominant ground-glass opacity.
Yang Y; Yang Y; Zhou X; Song X; Liu M; He W; Wang H; Wu C; Fei K; Jiang G
Lung Cancer; 2015 Mar; 87(3):272-7. PubMed ID: 25582278
[TBL] [Abstract][Full Text] [Related]
7. Should resection extent be decided by total lesion size or solid component size in ground glass opacity-containing lung adenocarcinomas?
Lin B; Wang R; Chen L; Gu Z; Ji C; Fang W
Transl Lung Cancer Res; 2021 Jun; 10(6):2487-2499. PubMed ID: 34295656
[TBL] [Abstract][Full Text] [Related]
8. Volume doubling time of lung adenocarcinomas considering epidermal growth factor receptor mutation status of exon 19 and 21: three-dimensional volumetric evaluation.
Zhang R; Chen B; Zhou Y; Zhou P; Jin J; Zhao L; Li W
J Thorac Dis; 2017 Nov; 9(11):4387-4397. PubMed ID: 29268508
[TBL] [Abstract][Full Text] [Related]
9. Influence of Ground Glass Opacity and the Corresponding Pathological Findings on Survival in Patients with Clinical Stage I Non-Small Cell Lung Cancer.
Aokage K; Miyoshi T; Ishii G; Kusumoto M; Nomura S; Katsumata S; Sekihara K; Tane K; Tsuboi M
J Thorac Oncol; 2018 Apr; 13(4):533-542. PubMed ID: 29246833
[TBL] [Abstract][Full Text] [Related]
10. Volume Doubling Times of Lung Adenocarcinomas: Correlation with Predominant Histologic Subtypes and Prognosis.
Park S; Lee SM; Kim S; Lee JG; Choi S; Do KH; Seo JB
Radiology; 2020 Jun; 295(3):703-712. PubMed ID: 32228296
[TBL] [Abstract][Full Text] [Related]
11. Distinct Clinicopathologic Characteristics and Prognosis Based on the Presence of Ground Glass Opacity Component in Clinical Stage IA Lung Adenocarcinoma.
Hattori A; Hirayama S; Matsunaga T; Hayashi T; Takamochi K; Oh S; Suzuki K
J Thorac Oncol; 2019 Feb; 14(2):265-275. PubMed ID: 30368010
[TBL] [Abstract][Full Text] [Related]
12. Radiological evidence of rapid growth acceleration of a small part solid nodule found to be large-cell carcinoma of the lung.
Lu Y; Sun Z; Li H; Chen X; Li Y; Sun L; Yang F; Jiang G; Zhou J
J Cardiothorac Surg; 2023 Jul; 18(1):236. PubMed ID: 37488608
[TBL] [Abstract][Full Text] [Related]
13. Prognostic influence of a ground-glass opacity component in hypermetabolic lung adenocarcinoma.
Hattori A; Matsunaga T; Fukui M; Takamochi K; Suzuki K
Eur J Cardiothorac Surg; 2022 Jan; 61(2):249-256. PubMed ID: 34632486
[TBL] [Abstract][Full Text] [Related]
14. Surgical Outcomes of Lobectomy Versus Limited Resection for Clinical Stage I Ground-Glass Opacity Lung Adenocarcinoma 2 Centimeters or Smaller.
Zhang C; He Z; Cheng J; Cao J; Hu J
Clin Lung Cancer; 2021 Mar; 22(2):e160-e168. PubMed ID: 33160898
[TBL] [Abstract][Full Text] [Related]
15. Transition of Treatment for Ground Glass Opacity-Dominant Non-Small Cell Lung Cancer.
Handa Y; Tsutani Y; Okada M
Front Oncol; 2021; 11():655651. PubMed ID: 33937064
[TBL] [Abstract][Full Text] [Related]
16. Does ground glass opacity-dominant feature have a prognostic significance even in clinical T2aN0M0 lung adenocarcinoma?
Nakamura S; Fukui T; Kawaguchi K; Fukumoto K; Hirakawa A; Yokoi K
Lung Cancer; 2015 Jul; 89(1):38-42. PubMed ID: 25963638
[TBL] [Abstract][Full Text] [Related]
17. A retrospective study of volume doubling time in surgically resected non-small cell lung cancer.
Mackintosh JA; Marshall HM; Yang IA; Bowman RV; Fong KM
Respirology; 2014 Jul; 19(5):755-62. PubMed ID: 24797504
[TBL] [Abstract][Full Text] [Related]
18. Effects of a ground-glass opacity component on the recurrence and survival of pathological stage IA3 lung adenocarcinoma: a multi-institutional retrospective study.
Xu SJ; Chen RQ; Tu JH; You CX; Chen C; Zhang ZF; Divisi D; Migliore M; Bongiolatti S; Durand M; Sato M; Kuroda H; Yang CF; Yu SB; Chen SC
Transl Lung Cancer Res; 2023 May; 12(5):1078-1092. PubMed ID: 37323166
[TBL] [Abstract][Full Text] [Related]
19. Presence of Even a Small Ground-Glass Component in Lung Adenocarcinoma Predicts Better Survival.
Berry MF; Gao R; Kunder CA; Backhus L; Khuong A; Kadoch M; Leung A; Shrager J
Clin Lung Cancer; 2018 Jan; 19(1):e47-e51. PubMed ID: 28743420
[TBL] [Abstract][Full Text] [Related]
20. Prognostic Classification of Multiple Primary Lung Cancers Based on a Ground-Glass Opacity Component.
Hattori A; Takamochi K; Oh S; Suzuki K
Ann Thorac Surg; 2020 Feb; 109(2):420-427. PubMed ID: 31593656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
